A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list
Authors:
Open Access
- 23 January 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 56 (1) , 149-156
Abstract
In many countries, the allocation of liver grafts is based on the Model of End-stage Liver Disease (MELD) score and the use of exception points for patients with hepatocellular carcinoma (HCC). With this strategy, HCC patients have easier access to transplantation than non-HCC ones. In addition, this system does not allow for a dynamic assessment, which would be required to picture the current use of local tumor treatment. This study was based on the Scientific Registry of Transplant Recipients and included 5,498 adult candidates of a liver transplantation for HCC and 43,528 for non-HCC diagnoses. A proportional hazard competitive risk model was used. The risk of dropout of HCC patients was independently predicted by MELD score, HCC size, HCC number, and alpha-fetoprotein. When combined in a model with age and diagnosis, these factors allowed for the extrapolation of the risk of dropout. Because this model and MELD did not share compatible scales, a correlation between both models was computed according to the predicted risk of dropout, and drop-out equivalent MELD (deMELD) points were calculated. Conclusion: The proposed model, with the allocation of deMELD, has the potential to allow for a dynamic and combined comparison of opportunities to receive a graft for HCC and non-HCC patients on a common waiting list. (HEPATOLOGY 2012;56:149–156)Keywords
Funding Information
- Swiss National Science Foundation (SCORE grant 3232230-126233)
- Canada Institutes of Health Research/Wyeth Research Chair in Transplantation
- Senior Scholar of the Alberta Heritage Foundation for Medical Research
- Artères Foundation and the Astellas Foundation Europe
This publication has 17 references indexed in Scilit:
- The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinomaJournal of Hepatology, 2011
- Empirical Transition Matrix of Multi-State Models: TheetmPackageJournal of Statistical Software, 2011
- Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation SystemAmerican Journal of Transplantation, 2010
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisThe Lancet Oncology, 2009
- Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinomaLiver Transplantation, 2008
- Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysisHepatology, 2008
- Waiting List Removal Rates Among Patients with Chronic and Malignant Liver DiseasesAmerican Journal of Transplantation, 2006
- Model for end-stage liver disease (MELD) and allocation of donor liversGastroenterology, 2003
- A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shuntsHepatology, 2000
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996